News Releases

The latest news releases from Fresenius Medical Care North America

For media inquiries, please contact or 781-699-5280

Fresenius Medical Care Sells Sound Inpatient Physicians Holdings for $2.15 Billion

published April 21, 2018

Fresenius Medical Care, the world’s largest provider of dialysis products and services, today announced an important strategic step to sharpen its U.S. Care Coordination profile with the signing of a definitive agreement to divest its controlling interest in Sound Inpatient Physicians Holdings, LLC (Sound) to an investment consortium led by Summit Partners (Summit), for total transaction proceeds of $2.15 billion (EUR 1.76 billion).

FMCNA, ANNA Announce Recipients of Nursing Educational Scholarships

published April 18, 2018

As part of an ongoing commitment to support nurses dedicated to caring for patients with kidney disease, Fresenius Medical Care North America (FMCNA), the nation’s leading renal care company, and the American Nephrology Nurses Association (ANNA) announced five recipients of educational scholarships at ANNA’s 2018 National Symposium in Las Vegas.

FMCNA Appoints Angela McClure to Chief Experience Officer

published March 19, 2018

Fresenius Medical Care North America (FMCNA), the country’s leading provider of kidney care products and services, announces the appointment of Angela McClure to the newly created role of chief experience officer (CXO).

Abstracts on Velphoro® Accepted for Presentation at the American Society of Nephrology Kidney Week

published November 3, 2017

Fresenius Medical Care Renal Therapies Group announced today that four abstracts on Velphoro® (sucroferric oxyhydroxide) have been accepted for presentation at the American Society of Nephrology (ASN) annual Kidney Week held Oct. 31-Nov. 5, 2017 in New Orleans. The abstracts describe the real world outcomes in serum phosphorus control and a significant reduction in pill burden achieved in hemodialysis patients who switched to Velphoro as part of their routine clinical care.